COAGULOPATHY OF CHILDHOOD NEPHROTIC SYNDROME - A REAPPRAISAL OF THE ROLE OF NATURAL ANTICOAGULANTS AND FIBRINOLYSIS

Citation
Mm. Almugeiren et al., COAGULOPATHY OF CHILDHOOD NEPHROTIC SYNDROME - A REAPPRAISAL OF THE ROLE OF NATURAL ANTICOAGULANTS AND FIBRINOLYSIS, Haemostasis, 26(6), 1996, pp. 304-310
Citations number
24
Categorie Soggetti
Hematology
Journal title
ISSN journal
03010147
Volume
26
Issue
6
Year of publication
1996
Pages
304 - 310
Database
ISI
SICI code
0301-0147(1996)26:6<304:COCNS->2.0.ZU;2-M
Abstract
In an attempt to characterise further the coagulopathy of childhood ne phrotic syndrome, this study concentrates on simultaneous measurements of the natural anticoagulants [antithrombin III (ATIII), proteins C a nd S] and the fibrinolytic factors, tissue plasminogen activator (tPA) and plasminogen activator inhibitor (PAI). The study groups consisted of 41. children (ages ranging from 2 to 14 years; median 7.1) in the relapse of nephrosis and 48 children (ages ranging from 3 to 14 years; median 7.6) in remission. The results obtained were compared with nor mal values obtained in healthy age- and sex-matched controls (n = 103) . During relapse, there was a marked increase in the plasma level of f ibrinogen, protein C, and protein S and reduced plasma ATIII level; tP A level was similar to control but PAI level exhibited a significant r eduction. During remission, the protein C level either remained elevat ed or increased further, but some decreased. Protein S and plasma ATII I level normalised. The fibrinolytic activator tPA dropped slightly bu t the PAI level remained significantly below control levels. We conclu de that in the relapse of childhood nephrosis, despite the existence o f a significant prothrombotic tendency as featured by hyperfibrinogena emia and markedly reduced ATIII level, the simultaneous elevation of t he natural anticoagulant, protein C level and enhanced fibrinolysis th at persist until the remission phase, seem to be major preventive mech anisms guarding nephrotic children against thromboembolic phenomena.